Healthcare
Technology
People

Healthcare
Technology
People

Portfolio
People
Stories & Ideas
About
Fintech Index
FBRI
Jobs

Search for:

Find a portfolio company, person, community initiative, or story

News

Category

Enterprise IT
FinTech
Health IT/Services
MedTech
Other
Therapeutics

PR Newswire

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
June 19, 2020
Business Wire

Jackie Schumacher Joins Rallybio to Lead Global Regulatory Affairs
June 19, 2020
PR Newswire

Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China
June 18, 2020
GlobeNewswire

Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial
June 18, 2020
GlobeNewswire

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
June 18, 2020
Business Wire

Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors
June 17, 2020
GlobeNewswire

Flywire Survey Reveals Consumers Upbeat About Travel Post COVID-19
June 17, 2020
PR Newswire

Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 16, 2020
GlobeNewswire

Hua Medicine’s Dorzagliatin Demonstrates Improvements in β-Cell Function in Data Presented at the American Diabetes Association’s 80th Scientific Sessions
June 15, 2020
Snapsheet Drives Digital Payments for Clearcover Claimants and Vendors
June 15, 2020
Business Wire

Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
June 15, 2020
ExpressPharma

Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP
June 12, 2020
Reuters

Apellis Pharmaceuticals Says Phase 3 Pegasus Study For Pegcetacoplan Met Primary Endpoint For Efficacy
June 12, 2020
FierceBiotech

Biotech Verve banks $63M to move gene-editing heart attack treatment toward clinic
June 11, 2020
Xconomy

Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
June 11, 2020
PR Newswire

Avidity Biosciences Announces Pricing of Initial Public Offering
June 11, 2020
PR Newswire

Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories
June 10, 2020
Business Wire

Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
June 10, 2020
PR Newswire

PatientPing Secures $60 Million in Series C Funding to Continue Expansion of National Electronic Notifications Network
June 9, 2020
GlobeNewswire

Denali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With Sanofi
June 9, 2020
GlobeNewswire

Flywire Improves Healthcare Patient Engagement and Affordability During COVID-19
June 9, 2020
PR Newswire

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis
June 9, 2020
PR Newswire

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies
June 9, 2020
PR Newswire

Buoy Health Launches Back with CareTM and Forms Advisory Board to Support Safe Return to the Workplace
June 8, 2020
Nasdaq

Muscle disorder biotech Avidity Biosciences sets terms for $150 million IPO
June 8, 2020
GlobeNewswire

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
June 8, 2020
GlobeNewswire

Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
June 8, 2020
Business Wire

NodThera Announces Close of $55 Million Series B Financing
June 3, 2020
PR Newswire

Innovent Announces the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
June 1, 2020
PR Newswire

TraceLink Achieves ISO 9001:2015 Certification for Quality Management
June 1, 2020
GlobeNewswire

Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap Index
May 31, 2020
PR Newswire

TraceLink Introduces New Agile Issue Management Solution
May 28, 2020
PR Newswire

Firefly Health Launches Return To Work Service To Support The Reopening Plans Of Massachusetts Businesses
May 28, 2020
VentureBeat

Optimus Ride begins delivering food to families in need in Washington, D.C.
May 28, 2020
GlobeNewswire

Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
May 27, 2020
GlobeNewswire

Arvelle Announces Closing of Final Tranche of Series A Financing Round
May 26, 2020
PR Newswire

KCNT1 Epilepsy Foundation, LunaPBC, and Genetic Alliance to Launch Patient-Led Discovery Program
May 26, 2020
FierceBiotech

Biotech Muscle disorder biotech Avidity aims for the clinic with $100M IPO
May 26, 2020
GlobeNewswire

Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
May 21, 2020
FierceBiotech

Rallybio scores $145M, unveils lead rare disease program
May 19, 2020
PR Newswire

Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers
May 18, 2020
GlobeNewswire

Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I
May 15, 2020
GlobeNewswire

Ultragenyx Announces Positive Data from Confirmatory Cohort of Phase 1/2 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
May 15, 2020
HIT Consultant

Boston Children’s Hospital Taps Kyruus to Power Digital Access Initiatives
May 14, 2020
PR Newswire

TraceLink Hosts Webinar to Help Pharma Prepare for Supply Chain Disruptions in the “Next Normal”
May 14, 2020
MedCityNews

With new lung cancer data at ASCO, Blueprint Medicines nips at Eli Lilly’s heels
May 14, 2020
GlobeNewswire

Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
May 13, 2020
PR Newswire

TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020
GlobeNewswire

SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets – Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
May 12, 2020
GlobeNewswire

Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy
May 12, 2020
FierceBiotech

Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead
May 12, 2020
PR Newswire

Shift Technology and Snapsheet Partner to Add Fraud Detection to Snapsheet Claims Management Platform
May 11, 2020
GlobeNewswire

Tempest Therapeutics Announces First Patient Dosed in TPST-1495 Clinical Study: Dual EP2/4 Antagonist Targeting Solid Tumors
May 7, 2020
PR Newswire

FARAPULSE’s Pioneering Clinical Results Link Compelling Long-term Outcomes to Established Safety and Lesion Durability Data
May 7, 2020
TechCrunch

Owkin raises $25 million as it builds a secure network for healthcare analysis and research
May 7, 2020
Forbes

Tradier Teams With Q.ai, A Forbes Company, To Bring AI And Big Data Analytics To Customers And Retail Investors
May 7, 2020
PR Newswire

Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
May 7, 2020
PR Newswire

Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
May 6, 2020
Business Wire

OCC Selects Axoni to Modernize Securities Lending Infrastructure
May 5, 2020
GlobeNewswire

Snapsheet Brings Claims Management Platform to Clearcover
May 5, 2020
GlobeNewswire

GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
May 4, 2020
Business Wire

SonderMind hires Douglas Newton, MD, MPH as Chief Medical Officer
May 4, 2020
PR Newswire

Whatfix Named a Finalist for Business Intelligence Group’s 2020 Excellence in Customer Service Award
April 30, 2020
EurekAlert

Frost & Sullivan recognizes Insilico as innovation leader in drug discovery
April 30, 2020
PR Newswire

Pharmaceutical Manufacturers and Wholesalers Continue to Choose TraceLink As Industry Readies for DSCSA Saleable Returns Verification Requirement
April 29, 2020
GlobeNewswire

Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
April 28, 2020
Business Wire

Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio
April 27, 2020
PR Newswire

Innovent Announces First Patient Dosed in a Pivotal Trial of Parsaclisib in Patients with Indolent Lymphoma in China
April 27, 2020
PR Newswire

Novaerus Defend 1050 Proven to Reduce Coronavirus Surrogate by 99.99%
April 27, 2020
Business Wire

Xilio Therapeutics Appoints Martin H. Huber, M.D. as Chief Medical Officer
April 27, 2020
PR Newswire

Applied BioMath, LLC Announces Collaboration with Xilio Therapeutics
April 27, 2020
Business Wire

Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
April 27, 2020
GlobeNewswire

Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA)
April 27, 2020
PR Newswire

Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
April 27, 2020
GlobeNewswire

Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
April 26, 2020
PR Newswire

Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
April 23, 2020
GlobeNewswire

Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
April 23, 2020
GlobeNewswire

Flywire Unveils Framework to Help Universities Increase Fall 2020 Enrollment
April 23, 2020
PR Newswire

Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
April 20, 2020
PR Newswire

TraceLink Announces $1 Million Charitable Funding for COVID-19 Relief, Issues Call for Grant Proposals
April 16, 2020
GlobeNewswire

Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources
April 15, 2020
FierceBiotech

Boehringer Ingelheim taps Insilico Medicine for AI drug target collaboration
April 14, 2020
PR Newswire

Centivo Launches New Health Plan Solution
April 9, 2020
GlobeNewswire

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL
April 7, 2020
Business Wire

Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline
April 7, 2020
Business Wire

SonderMind Raises $27 Million to Expand its Accessible Behavioral Health Platform
April 6, 2020
FierceBiotech

Compass Therapeutics’ immuno-oncology prospect clears solid tumors in mice
April 3, 2020
PR Newswire

Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
April 1, 2020
GlobeNewswire

Orchard Therapeutics Outlines Business Impact of COVID-19
March 31, 2020
GlobeNewswire

REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
March 31, 2020

page 1 1
page 2 2
page 3 3
page 4 4
page 5 5
page 6 6
page 7 7
page 8 8
page 9 9
page 10 10
page 11 11
page 12 12
page 13 13
page 14 14
page 15 15
page 16 16
page 17 17
page 18 18
page 19 19
page 20 20
page 21 21
page 22 22
page 23 23
page 24 24
page 25 25

We create and invest in healthcare and technology companies that improve lives all over the world.

Get the latest updates

Healthcare Technology

We respect your privacy.

Get the latest updates

Healthcare Technology

We respect your privacy.

Leave this field empty if you're human:

Jump to —

Portfolio
People
Stories & Ideas
About
Fintech Index
FBRI
Jobs

Cambridge
1 Main St.
13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

© 2024
Terms of Use
Privacy Policy
Stay in Touch

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC. As of July 1, 2024, F-Prime advises Fine Structure Ventures (https://finestructure.vc/).